Case number 2018-1335
Cosmo Technologies Limited v. Actavis Laboratories FL, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | COSMO TECHNOLOGIES LIMITED v. ACTAVIS LABORATORIES FL, INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 20, 2019 | 86 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [587368] [18-1335, 18-1336] [PBC] [Entered: 02/20/2019 10:30 AM] (2) |
| Feb 20, 2019 | 85 | ORDER filed re: bill of costs/fees [83] filed by Appellee Alvogen Pine Brook, LLC. The costs are taxed according to the bill of costs as filed. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [587344] [JAB] [Entered: 02/20/2019 09:48 AM] (2) |
| Feb 11, 2019 | 84 | Letter from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. objecting to the Bill of Costs submitted by Alvogen Pine Brook LLC (Dkt. #83) pursuant to Federal Rule of Appellate Procedure 39 and Federal Circuit Rule 39. Service: 02/11/2019 by email. [585034] [18-1335] [Stephen Kinnaird] [Entered: 02/11/2019 11:04 PM] (2) |
| Feb 6, 2019 | 83 | Bill of Costs for Appellee Alvogen Pine Brook, LLC. Service: 02/06/2019 by email. Objection to Bill of Costs due on 02/20/2019. [583877] [18-1335] [Matthew Becker] [Entered: 02/06/2019 04:06 PM] (0) |
| Jan 30, 2019 | 82 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Alvogen Pine Brook, LLC, Bill of Costs [81], is not in compliance with the rules of this court (see attached). Compliant document due on 02/06/2019. Service as of this date by the Clerk of Court.[581959] [JAB] [Entered: 01/30/2019 09:25 AM] (1) |
| Jan 28, 2019 | 81 | Bill of Costs for Appellee Alvogen Pine Brook, LLC. Service: 01/28/2019 by email. Objection to Bill of Costs due on 02/11/2019. [581497] [18-1335] This document is non-compliant. See Doc. No. [82]. [Matthew Becker] [Entered: 01/28/2019 03:47 PM] (0) |
| Jan 25, 2019 | 80 | Bill of Costs for Appellee Actavis Laboratories FL, Inc.. Service: 01/25/2019 by email. Objection to Bill of Costs due on 02/08/2019. [580919] [18-1335] [William Jay] [Entered: 01/25/2019 11:14 AM] (0) |
| Jan 14, 2019 | 79 | JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [577869] [18-1335, 18-1336] [PBC] [Entered: 01/14/2019 09:36 AM] (3) |
| Jan 10, 2019 | 78 | Submitted after ORAL ARGUMENT by Stephen Blake Kinnaird for Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.a.r.l., and Cosmo Technologies Limited, William M. Jay for Actavis Laboratories FL, Inc. and Jason Murata for Alvogen Pine Brook, LLC. Panel: Judge: Prost , Judge: Reyna , Judge: Taranto. [577255] [JAB] [Entered: 01/10/2019 11:08 AM] (0) |
| Jan 7, 2019 | 77 | RESPONSE of Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC to the supplemental authority [76] filed by Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/07/2019 by email. [576493] [18-1335] [William Jay] [Entered: 01/07/2019 06:14 PM] (3) |
| Jan 4, 2019 | 76 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/04/2019 by email. [576097] [18-1335] [Stephen Kinnaird] [Entered: 01/04/2019 08:00 PM] (3) |
| Dec 17, 2018 | 75 | Response to notice of oral argument from the Appellee Alvogen Pine Brook, LLC. [572380] [18-1335] [Matthew Becker] [Entered: 12/17/2018 04:44 PM] (3) |
| Dec 17, 2018 | 74 | Response to notice of oral argument from the Appellants Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.a.r.l. and Cosmo Technologies Limited. [572362] [18-1335] [Stephen Kinnaird] [Entered: 12/17/2018 04:31 PM] (3) |
| Dec 17, 2018 | 73 | Response to notice of oral argument from the Appellee Actavis Laboratories FL, Inc.. [572348] [18-1335] [William Jay] [Entered: 12/17/2018 04:23 PM] (3) |
| Nov 19, 2018 | 72 | NOTICE OF ORAL ARGUMENT. Panel: 1901L. Case scheduled Jan 10, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 12/17/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [566387] [JAB] [Entered: 11/19/2018 03:25 PM] (2) |
| Jul 13, 2018 | 71 | Notice from Appellants Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. regarding conflicts with oral argument (Counsel for Cosmo will be unavailable September 4, and October 3-5. Counsel for Valeant will be unavailable September 4-5, and 7.). Service: 07/13/2018 by email. [535941] [18-1335] [Stephen Kinnaird] [Entered: 07/13/2018 07:22 PM] (2) |
| Jul 13, 2018 | 70 | Notice from Appellee Alvogen Pine Brook, LLC regarding conflicts with oral argument (October 2-5, 2018; November 9, 2018 and December 3-7, 2018). Service: 07/13/2018 by email. [535806] [18-1335] [Matthew Becker] [Entered: 07/13/2018 01:35 PM] (2) |
| Jul 13, 2018 | 69 | Notice from Appellee Actavis Laboratories FL, Inc. regarding conflicts with oral argument (September 4-7, October 1-3, December 3-7.). Service: 07/13/2018 by email. [535792] [18-1335] [William Jay] [Entered: 07/13/2018 01:17 PM] (2) |
| Jul 12, 2018 | 68 | 6 paper copies of the Confidential Joint Appendix Brief [65] received from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. [535361] [CJF] [Entered: 07/12/2018 10:15 AM] (0) |
| Jul 6, 2018 | 67 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [SEP, OCT, NOV], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/13/2018. [534151] [MJL] [Entered: 07/06/2018 04:30 PM] (0) |
| Jul 3, 2018 | 66 | APPENDIX FILED for Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [64]. Number of Pages: 496. Service: 07/03/2018 by email. Paper copies should be provided of the confidential version only. [534142] [MJL] [Entered: 07/06/2018 04:19 PM] (496) |
| Jul 3, 2018 | 65 | CONFIDENTIAL JOINT APPENDIX FILED for Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [63]. Number of Pages: 496. Service: 07/03/2018 by email. The paper copies of the confidential version of the appendix should be received by the court on or before 07/13/2018. [534140] [MJL] [Entered: 07/06/2018 04:17 PM] (0) |
| Jul 3, 2018 | 64 | TENDERED from Appellees Actavis Laboratories FL, Inc., Alvogen Pine Brook, LLC and Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: JOINT APPENDIX. Service: 07/03/2018 by email. [533625] [18-1335] [Stephen Kinnaird] [Entered: 07/03/2018 11:26 PM] (496) |
| Jul 3, 2018 | 63 | TENDERED from Appellees Actavis Laboratories FL, Inc., Alvogen Pine Brook, LLC and Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: CONFIDENTIAL JOINT APPENDIX Service: 07/03/2018 by email. [533624] [18-1335] [Stephen Kinnaird] [Entered: 07/03/2018 11:03 PM] (0) |
| Jul 3, 2018 | 62 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 07/03/2018 by email. [533623] [18-1335] [Stephen Kinnaird] [Entered: 07/03/2018 10:16 PM] (3) |
| Jul 3, 2018 | 61 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellees Actavis Laboratories FL, Inc., Alvogen Pine Brook, LLC and Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 07/03/2018 by email. [533622] [18-1335] [Stephen Kinnaird] [Entered: 07/03/2018 10:11 PM] (4) |
| Jul 3, 2018 | 60 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Alvogen Pine Brook, LLC. Service: 07/03/2018 by email. [533456] [18-1335] [Matthew Becker] [Entered: 07/03/2018 01:07 PM] (3) |
| Jul 3, 2018 | 59 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Actavis Laboratories FL, Inc.. Service: 07/03/2018 by email. [533445] [18-1335] [William Jay] [Entered: 07/03/2018 12:31 PM] (3) |
| Jun 28, 2018 | 58 | 6 paper copies of the Confidential Joint Reply Brief [56] received from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. [532508] [CJF] [Entered: 06/28/2018 11:54 AM] (0) |
| Jun 26, 2018 | 57 | REPLY BRIEF FILED for Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [55]. Number of Pages: 32. Service: 06/26/2018 by email. Appendix is due 07/03/2018. [532226] [CFT] [Entered: 06/27/2018 10:36 AM] (44) |
| Jun 26, 2018 | 56 | CONFIDENTIAL REPLY BRIEF FILED for Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [54]. Number of Pages: 32. Service: 06/26/2018 by email. The paper copies of the brief should be received by the court on or before 07/05/2018. [532224] [CFT] [Entered: 06/27/2018 10:34 AM] (0) |
| Jun 26, 2018 | 55 | TENDERED from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: REPLY BRIEF. Service: 06/26/2018 by email. [532133] [18-1335] [Stephen Kinnaird] [Entered: 06/26/2018 10:07 PM] (44) |
| Jun 26, 2018 | 54 | TENDERED from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: CONFIDENTIAL REPLY BRIEF Service: 06/26/2018 by email. [532132] [18-1335] [Stephen Kinnaird] [Entered: 06/26/2018 10:02 PM] (0) |
| May 30, 2018 | 53 | **TEXT ONLY** ORDER granting motion to extend time to file brief [52] filed by Appellants Valeant Pharmaceuticals International, Cosmo Technologies Limited and Valeant Pharmaceuticals Luxembourg S.a.r.l. The reply brief is due 06/26/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [525365] [CFT] [Entered: 05/30/2018 11:58 AM] (0) |
| May 29, 2018 | 52 | MOTION of Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. to extend the time to 06/26/2018 to file the Appellants' Reply Brief; Declaration of Stephen B. Kinnaird in Support. [Consent: unopposed]. Service: 05/29/2018 by email. [525229] [18-1335] [Stephen Kinnaird] [Entered: 05/29/2018 09:03 PM] (13) |
| May 25, 2018 | 51 | 6 paper copies of the Confidential Opening Response Joint Brief [49] received from Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC. [525033] [CJF] [Entered: 05/29/2018 01:13 PM] (0) |
| May 24, 2018 | 50 | 6 paper copies of the Corrected Confidential Opening Brief [42] received from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [524571] [JCP] [Entered: 05/25/2018 07:12 AM] (0) |
| May 24, 2018 | 47 | CORRECTED certificate of service for Appellees Alvogen Pine Brook, LLC and Actavis Laboratories FL, Inc. for confidential Brief, Doc No. [45]. Service: 05/24/2018 by email. [524459] [18-1335] [William Jay] [Entered: 05/24/2018 03:40 PM] (1) |
| May 22, 2018 | 44 | Amended Certificate of Interest for the Appellee Alvogen Pine Brook, LLC. Service: 05/22/2018 by email. [523532] [18-1335] [Matthew Becker] [Entered: 05/22/2018 11:12 AM] (3) |
| May 22, 2018 | 45 | TENDERED from Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC. Title: CONFIDENTIAL RESPONSE BRIEF Service: 05/22/2018 by email. [523731] [18-1335] [William Jay] [Entered: 05/22/2018 06:40 PM] (0) |
| May 22, 2018 | 46 | TENDERED from Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC. Title: RESPONSE BRIEF. Service: 05/22/2018 by email. [523733] [18-1335] [William Jay] [Entered: 05/22/2018 07:05 PM] (75) |
| May 22, 2018 | 48 | CONFIDENTIAL BRIEF FILED for Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC [45]. Number of Pages: 61. Service: 05/22/2018 by email. The paper copies of the confidential version of the brief should be received by the court on or before 06/01/2018. [524464] [MJL] [Entered: 05/24/2018 03:44 PM] (0) |
| May 22, 2018 | 49 | BRIEF FILED for Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC [46]. Number of Pages: 61. Service: 05/22/2018 by email. Appellants' reply brief is due 06/05/2018. [524470] [MJL] [Entered: 05/24/2018 03:55 PM] (75) |
| May 18, 2018 | 41 | ORDER filed granting motion to waive confidentiality requirements [38] filed by Appellants Valeant Pharmaceuticals International, Cosmo Technologies Limited and Valeant Pharmaceuticals Luxembourg S.a.r.l. The confidential and nonconfidential versions of Cosmo’s corrected opening brief are accepted for filing. Service: 05/18/2018 by clerk. [522836] [NL] [Entered: 05/18/2018 12:15 PM] (3) |
| May 18, 2018 | 42 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [39]. Number of Pages: 67. Service: 05/07/2018 by email. The paper copies of the brief should be received by the court on or before 05/25/2018. [523007] [CFT] [Entered: 05/18/2018 04:19 PM] (0) |
| May 18, 2018 | 43 | CORRECTED BRIEF FILED for Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. [40]. Number of Pages: 67. Service: 05/07/2018 by email. Appellees brief is due 06/18/2018. [523011] [CFT] [Entered: 05/18/2018 04:28 PM] (124) |
| May 7, 2018 | 40 | TENDERED from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: CORRECTED OPENING BRIEF. Service: 05/07/2018 by email. [519852] [18-1335] [Stephen Kinnaird] [Entered: 05/07/2018 10:40 PM] (124) |
| May 7, 2018 | 39 | TENDERED from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 05/07/2018 by email, US mail. [519851] [18-1335] [Stephen Kinnaird] [Entered: 05/07/2018 10:35 PM] (0) |
| May 7, 2018 | 38 | MOTION of Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. to waive confidentiality requirements [Consent: unopposed]. Service: 05/07/2018 by email. [519850] [18-1335] [Stephen Kinnaird] [Entered: 05/07/2018 10:30 PM] (11) |
| Apr 27, 2018 | 37 | ORDER filed. The motion [32] is denied without prejudice to Cosmo filing a corrected brief or a new motion with a corrected brief to the extent provided herein within 10 days of the date of filing of this order. Service: 04/27/2018 by clerk. [517506] [NL] [Entered: 04/27/2018 04:46 PM] (4) |
| Apr 26, 2018 | 36 | ORDER granting motion to extend time to file brief [35] filed by Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC. Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC response brief due 05/22/2018. Service: 04/26/2018 by clerk. [517030] [NL] [Entered: 04/26/2018 10:40 AM] (2) |
| Apr 23, 2018 | 35 | MOTION of Appellees Actavis Laboratories FL, Inc. and Alvogen Pine Brook, LLC to extend the time to 05/22/2018 to file the Response Brief. [Consent: unopposed]. Service: 04/23/2018 by email, US mail. [516223] [18-1335] [William Jay] [Entered: 04/23/2018 07:38 PM] (9) |
| Mar 22, 2018 | 34 | TENDERED from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: OPENING BRIEF. Service: 03/22/2018 by email. [507406] [18-1335] This brief has been corrected. See Doc No. [43] [Stephen Kinnaird] [Entered: 03/22/2018 11:49 PM] (0) |
| Mar 22, 2018 | 33 | TENDERED from Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Title: CONFIDENTIAL OPENING BRIEF Service: 03/22/2018 by email, US mail. [507405] [18-1335] This brief has been corrected. See Doc No. [42] [Stephen Kinnaird] [Entered: 03/22/2018 11:17 PM] (0) |
| Mar 22, 2018 | 32 | MOTION of Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. to waive confidentiality requirements. Any response is due within 10 days of service. [Consent: unopposed]. Service: 03/22/2018 by email. [507404] [18-1335] [Stephen Kinnaird] [Entered: 03/22/2018 11:08 PM] (8) |
| Feb 8, 2018 | 31 | **TEXT ONLY** ORDER granting motion to extend time to file appellant principal brief [30] filed by Appellants Valeant Pharmaceuticals International, Cosmo Technologies Limited and Valeant Pharmaceuticals Luxembourg S.a.r.l. The brief is due 03/22/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [496079] [MJL] [Entered: 02/08/2018 08:19 AM] (0) |
| Feb 7, 2018 | 30 | MOTION of Appellants Cosmo Technologies Limited, Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l. to extend the time to 03/22/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/07/2018 by email. [496063] [Gary Frischling] [Entered: 02/07/2018 08:32 PM] (12) |
| Jan 8, 2018 | 29 | Corrected Entry of appearance for Jason T. Murata as of counsel for Appellee Alvogen Pine Brook, LLC. Service: 01/08/2018 by email, US mail. [488071] [Jason Murata] [Entered: 01/08/2018 04:19 PM] (2) |
| Jan 8, 2018 | 28 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Samuel Sherry (entry of appearance [19]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [488036] [MJL] [Entered: 01/08/2018 03:55 PM] (0) |
| Jan 8, 2018 | 27 | NOTICE OF DEFICIENCY: The docket text for the entry of appearance for Jason T. Murata [23] filed by Appellee Alvogen Pine Brook, LLC in 18-1335 is indicating more than one principal attorney for the party and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [488031] [MJL] [Entered: 01/08/2018 03:51 PM] (0) |
| Jan 5, 2018 | 26 | Docketing Statement for the Appellant Cosmo Technologies Limited. Service: 01/05/2018 by email. [487788] [Gary Frischling] [Entered: 01/05/2018 06:47 PM] (3) |
| Jan 5, 2018 | 25 | Amended Certificate of Interest for the Appellant Cosmo Technologies Limited. Service: 01/05/2018 by email. [487787] [Gary Frischling] [Entered: 01/05/2018 06:46 PM] (2) |
| Jan 5, 2018 | 24 | Docketing Statement for the Appellants Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/05/2018 by email. [487786] [Stephen Kinnaird] [Entered: 01/05/2018 06:31 PM] (3) |
| Jan 5, 2018 | 23 | Entry of appearance for Jason T. Murata as principal counsel for Appellee Alvogen Pine Brook, LLC. Service: 01/05/2018 by email, US mail. [487775] [Jason Murata] [Entered: 01/05/2018 05:14 PM] (0) |
| Jan 5, 2018 | 22 | Docketing Statement for the Appellee Alvogen Pine Brook, LLC. Service: 01/05/2018 by email, US mail. [487774] [Matthew Becker] [Entered: 01/05/2018 05:11 PM] (3) |
| Jan 5, 2018 | 21 | Certificate of Interest for the Appellee Alvogen Pine Brook, LLC. Service: 01/05/2018 by email, US mail. [487773] [Matthew Becker] [Entered: 01/05/2018 05:09 PM] (3) |
| Jan 5, 2018 | 20 | Entry of appearance for Matthew J. Becker as principal counsel for Appellee Alvogen Pine Brook, LLC. Service: 01/05/2018 by email, US mail. [487772] [Matthew Becker] [Entered: 01/05/2018 05:08 PM] (2) |
| Jan 5, 2018 | 19 | Entry of appearance for Samuel Sherry as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487742] [Elizabeth Holland] [Entered: 01/05/2018 04:04 PM] (2) |
| Jan 5, 2018 | 18 | Entry of appearance for John T. Bennett as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487741] [Elizabeth Holland] [Entered: 01/05/2018 04:03 PM] (2) |
| Jan 5, 2018 | 17 | Entry of appearance for Naomi Birbach as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487740] [Elizabeth Holland] [Entered: 01/05/2018 04:03 PM] (2) |
| Jan 5, 2018 | 16 | Entry of appearance for Joshua J. Bone as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487739] [Elizabeth Holland] [Entered: 01/05/2018 04:02 PM] (2) |
| Jan 5, 2018 | 15 | Entry of appearance for William M. Jay as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487738] [Elizabeth Holland] [Entered: 01/05/2018 04:01 PM] (2) |
| Jan 5, 2018 | 14 | Certificate of Interest for the Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487737] [Elizabeth Holland] [Entered: 01/05/2018 04:00 PM] (3) |
| Jan 5, 2018 | 13 | Docketing Statement for the Appellee Actavis Laboratories FL, Inc.. Service: 01/05/2018 by email. [487736] [Elizabeth Holland] [Entered: 01/05/2018 03:59 PM] (3) |
| Jan 5, 2018 | 12 | Entry of appearance for Elizabeth J. Holland as principal counsel for Appellee Actavis Laboratories FL, Inc. Service: 01/05/2018 by email. [487734]--[Edited 01/05/2018 by clerk to add party filer]. [Elizabeth Holland] [Entered: 01/05/2018 03:57 PM] (2) |
| Jan 5, 2018 | 11 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Yite John Lu (entry of appearance [5]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [487510] [MJL] [Entered: 01/05/2018 09:00 AM] (0) |
| Jan 4, 2018 | 10 | Certificate of Interest for the Appellants Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/04/2018 by email. [487489] [Stephen Kinnaird] [Entered: 01/04/2018 09:06 PM] (4) |
| Jan 4, 2018 | 9 | Entry of appearance for Stephen B. Kinnaird as principal counsel for Appellants Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/04/2018 by email. [487488] [Stephen Kinnaird] [Entered: 01/04/2018 09:03 PM] (2) |
| Jan 4, 2018 | 8 | Entry of appearance for Igor Victor Timofeyev as of counsel for Appellants Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/04/2018 by email. [487487] [Igor Timofeyev] [Entered: 01/04/2018 08:59 PM] (2) |
| Jan 4, 2018 | 7 | Entry of appearance for Melanie R. Rupert as of counsel for Appellants Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.a.r.l.. Service: 01/04/2018 by email. [487486] [Melanie Rupert] [Entered: 01/04/2018 08:54 PM] (2) |
| Jan 4, 2018 | 6 | Certificate of Interest for the Appellant Cosmo Technologies Limited. Service: 01/04/2018 by email. [487432] [Gary Frischling] [Entered: 01/04/2018 04:24 PM] (2) |
| Jan 4, 2018 | 5 | Entry of appearance for Yite John Lu as of counsel for Appellant Cosmo Technologies Limited. Service: 01/04/2018 by email. [487430] [Gary Frischling] [Entered: 01/04/2018 04:23 PM] (1) |
| Jan 4, 2018 | 4 | Entry of appearance for Gary N. Frischling as principal counsel for Appellant Cosmo Technologies Limited. Service: 01/04/2018 by email. [487429] [Gary Frischling] [Entered: 01/04/2018 04:21 PM] (1) |
| Jan 2, 2018 | 3 | Note to file: The following cases are consolidated: 18-1335 (Lead) with 18-1336 (Member). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [486584] [18-1335, 18-1336] [MJL] [Entered: 01/02/2018 12:00 PM] (0) |
| Jan 2, 2018 | 2 | ORDER consolidating appeals 18-1335 and 18-1336. The revised official caption is reflected in the order. Appellants' opening brief is due 02/20/2018. Service as of this date by Clerk of Court. [486582] [18-1335, 18-1336] [MJL] [Entered: 01/02/2018 11:59 AM] (2) |
| Dec 22, 2017 | 1 | Appeal docketed. Received: 12/22/2017. [485363]Entry of Appearance due 01/05/2018. Certificate of Interest due 01/05/2018. Docketing Statement due 01/05/2018. Appellants' brief due 02/20/2018. [MJL] [Entered: 12/22/2017 03:58 PM] (37) |
